Medistim is opening a direct sales office in Sweden

This move is part of the company's ongoing commitment to providing exceptional service to customers as well as fulfilling the company’s global growth strategy. The company is well positioned to continue its growth by further…

Read more

Presentation of Medistim’s Q2 2023 Financial Results

The financials will be presented via a live webinar on Thursday, August 31st from 08:00-09:00 (CEST). Representatives for the company will be Kari Eian Krogstad (CEO), and Thomas Jakobsen (CFO). The recording will be made available on…

Read more

Medistim announces partnership with ROMA-Women Trial

Medistim is pleased to announce its partnership with ROMA-Women, a groundbreaking cardiac surgery trial that is specifically focused on women. Historically, cardiovascular research and treatment protocols have primarily focused on men, leaving women underrepresented in…

Read more

Presentation of Medistim’s Q1 2023 Financial Results

The financials will be presented via a live webinar on Tuesday, April 25th from 08:00-09:00 (CEST). Representatives for the company will be Kari Eian Krogstad (CEO), and Thomas Jakobsen (CFO). The recording will be made available on…

Read more

Annual Report 2022

Further supported by several high-quality symposia at the largest heart surgery conferences, we achieved 44 % growth in the imaging product portfolio in 2022. And while steadily penetrating the Cardiac bypass market, we also build…

Read more

Capital Markets Day

See the recording from Medistim's Capital Markets Day on March 21st where two international thought leaders, Professors John. D. Puskas and Pirkka Vikatmaa shared their insights on the future trends in Cardiac and Vascular Surgery…

Read more